Table 1.
Groups | n | BI, mean (range) | Male:female | NDO-BSA positive, n (%) | LID-1 positive, n (%) | NDO-LID positive, n (%) | |
---|---|---|---|---|---|---|---|
Patients | MB | 74 | 3.01 (1.5–5.5) | 56:18 | 72 (97.3) | 72 (97.3) | 73 (98.6) |
PB | 39 | 0.22 (0–1.8) | 26:13 | 29 (74.4) | 22 (56.4) | 27 (69.23) | |
Controls | HHC-MB | 93 | – | 31:62 | 52 (57.4) | 21 (22.5) | 16 (14.8) |
HHC-PB | 15 | – | 8:7 | 6 (40.0) | 4 (26.7) | 0 (0) | |
TB | 27 | – | 20:7 | 6 (22.2) | 2 (7.4) | 1 (3.7) | |
EC | 31 | – | 18:13 | 5 (16.1) | 4 (12.9) | 5 (16.1) |
HHC-MB: household contact of an MB patient; HHC-PB: household contact of a PB patient.